Inventor

VANDENBARK ARTHUR A

US25 patents

⚠️ This page may combine multiple inventors who share the name “VANDENBARK ARTHUR A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VANDENBARK ARTHUR A

UNIV OREGON HEALTH & SCIENCE

Recombinant MHC molecules useful for manipulation of antigen-specific T-cells

Recombinant MHC molecules useful for manipulation of antigen-specific T-cells

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells

Methods of selecting T cell receptor V peptides for therapeutic use

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

Compositions and methods using recombinant MHC molecules for the treatment of stroke

Compositions and methods using recombinant MHC molecules for the treatment of stroke

Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use

Methods for detecting and treating autoimmune disorders

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

Recombinant polypeptides comprising MHC class II α1 domains

Recombinant CD74 polypeptides

Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor

(unassigned)

Treatment of CD4 T-cell mediated conditions

T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions

OREGON HEALTH & SCIENCES UNIVE

Method for direct electrical detection of molecules and molecule-molecule interactions

Device for direct electrical detection of molecules and molecule-molecule interactions

UNIV OREGON HEALTH SCIENCES

Recombinant MHC molecules useful for manipulation of antigen-specific T-cells

CONNECTIVE THERAPEUTICS INC

T cell receptor peptides as therapeutics for immune-related disease

CONNETICS CORP

TCR V beta 5 peptides

OFFNER HALINA

Compositions and methods using recombinant MHC molecules for the treatment of stroke

BURROWS GREGORY G

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

LOFTIS JENNIFER

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

ADAMUS GRAZYNA

Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)